Marimed (MRMD) Total Non-Current Liabilities (2011 - 2025)

Marimed (MRMD) has reported Total Non-Current Liabilities for 15 consecutive years, with $137.8 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Total Non-Current Liabilities rose 6.56% year-over-year to $137.8 million in Q4 2025; TTM through Dec 2025 was $137.8 million, a 6.56% increase from a year earlier, with the FY2025 full-year figure at $137.8 million, up 6.56% from the prior year.
• Total Non-Current Liabilities was $137.8 million for Q4 2025 at Marimed, up from $136.5 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $137.8 million in Q4 2025 and troughed at $37.5 million in Q1 2021.
• A 5-year average of $89.3 million and a median of $89.2 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities tumbled 36.32% in 2021 and soared 87.69% in 2023, its largest moves.
• Over 5 years, Total Non-Current Liabilities stood at $49.1 million in 2021, then increased by 16.27% to $57.1 million in 2022, then soared by 87.69% to $107.1 million in 2023, then grew by 20.76% to $129.3 million in 2024, then increased by 6.56% to $137.8 million in 2025.
• The last three Total Non-Current Liabilities figures came in at $137.8 million (Q4 2025), $136.5 million (Q3 2025), and $131.1 million (Q2 2025), per Business Quant data.